1 / 84

Program Goals

Program Goals. Overview of Following Talks. Major Outcomes in MS. Disease-Modifying Therapies. Interferon Beta: Mechanisms of Action. Interferon Beta: Pivotal Trials — CIS and RRMS. Trials of Interferon Beta in CIS. BENEFIT Trial: Interferon Beta -1b for CIS.

walker-craft
Télécharger la présentation

Program Goals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Program Goals

  2. Overview of Following Talks

  3. Major Outcomes in MS

  4. Disease-Modifying Therapies

  5. Interferon Beta: Mechanisms of Action

  6. Interferon Beta:Pivotal Trials — CIS and RRMS

  7. Trials of Interferon Beta in CIS

  8. BENEFIT Trial: Interferon Beta-1b for CIS

  9. REFLEX Trial: Interferon Beta-1aSC in Patients With CIS

  10. Interferon Beta-1b in SPMS: European and North American Trials

  11. Mortality for Interferon Beta-1b vs Placebo

  12. The Challenge of Choice

  13. The Physician’s Role

  14. DMT Choice Factors

  15. Case 1: Dan

  16. What Would You Tell This Patient?

  17. What Is the Single Most Important Therapeutic Issue at This Point?

  18. Is His History of Depression a Contraindication to Using an Interferon-Beta?

  19. What DMT Would You Recommend?

  20. Reviewing Treatment Options

  21. Interferon Beta and Depression

  22. Interferon Beta and Depression (cont)

  23. Interferon Beta: Positives

  24. Interferon Beta: Concerns

  25. Case 2: Dana

  26. Is Interferon Beta a Good Choice for This Patient?

  27. Interferon Beta Issues

  28. Interferon Beta Issues (cont)

  29. Summary

  30. A Multitude of Factors Contributeto Optimal MS Management

  31. Case Study 1: Lisa

  32. Case Study 1: Lisa (cont)

  33. Case Study 1: Lisa (cont)

  34. Management of Adverse Therapeutic Effects

  35. Management of Adverse Therapeutic Effects (cont)

  36. Case Study 1: Lisa (cont)

  37. Case Study 1: Lisa (cont)

  38. Case Study 2: Bill

  39. Case Study 2: Bill (cont)

  40. What Would Your Recommendation Be?

  41. Case Study 2: Bill (cont)

  42. What Are Your Next Steps?

  43. Case Study 2: Bill (cont)

  44. Case Study 2: Bill (cont)

  45. How Do You Begin to Counsel Bill?

  46. Case Study 2: Bill (cont)

More Related